Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
April 5, 2016 — New research shows individuals with a greater degree of activity in the stress center of the brain also ...
January 21, 2016 — Siemens Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
November 16, 2015 — GE Healthcare’s Molecular Imaging business will showcase the Discovery IQ positron emission ...
September 23, 2015 — New research describes a method, tested in rats, that may someday allow healthcare providers to ...
September 16, 2015 — A novel radiopharmaceutical probe developed at Massachusetts General Hospital (MGH) has the ...
June 29, 2015 - The Global Nuclear Medicine Diagnostics Market report from Mordor Intelligence revealed that North ...
June 11, 2015 - At the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 6-10 ...
June 8, 2015 - GE Healthcare announced that it has created a solution to make positron emission tomography (PET) tracers ...
June 8, 2015 - Steinberg Diagnostic Medical Imaging (SDMI) of Las Vegas has bolstered its capabilities by installing the ...
May 4, 2015 — Results from Lantheus Medical Imaging Inc.’s first Phase 3 study of flurpiridaz F 18 for myocardial ...
There have been several technology advances in PET/CT (positron emission tomography/computed tomography) systems ...
Based on its ongoing analysis of the medical imaging market, Frost & Sullivan recognizes Toshiba America Medical Systems ...
Nuclear myocardial perfusion imaging (MPI) with positron emission tomography (PET) and single-photon emission computed ...